FDA Inspection 760105 — Hemofarm AD Vrsac
The FDA completed an inspection of Hemofarm AD Vrsac on November 22, 2011 in Vrsac. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- November 22, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Vrsac (Serbia)